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Epigraph
The results suggest a helical structure.
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Abstract
Despite scientific advances, breast cancer still constitutes a worldwide major cause of death
among women. Given the great heterogeneity between cases, distinct classification schemes
have emerged. The intrinsic molecular subtype classification (luminal A, luminal B, HER2-
enriched and basal-like) accounts for the molecular characteristics and prognosis of tumors,
which provides valuable input for taking optimal treatment actions. Also, recent advance-
ments in molecular biology have provided scientists with high quality and diversity of omic-
like data, opening up the possibility of creating computational models for improving and
validating current subtyping systems. On this study, a Hopfield Network model for breast
cancer subtyping and characterization was created using data from The Cancer Genome
Atlas repository. Novel aspects include the usage of the network as a clustering mechanism
and the integrated use of several molecular types of data (gene mRNA expression, miRNA
expression and copy number variation). The results showed clustering capabilities for the
network, but even so, trying to derive a biological model from a Hopfield Network might
be difficult given the mirror attractor phenomena (every cluster might end up with an op-
posite). As a methodological aspect, Hopfield was compared with kmeans and OPTICS
clustering algorithms. The last one, surprisingly, hints at the possibility of creating a high
precision model that differentiates between luminal, HER2-enriched and basal samples us-
ing only 10 genes. The normalization procedure of dividing gene expression values by their
corresponding gene copy number appears to have contributed to the results. This opens up
the possibility of exploring these kind of prediction models for implementing diagnostic tests
at a lower cost.
Index Terms - Breast Cancer, Neural Networks, Machine Learning, Pattern Recognition,
Biocomputing.
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Resumen
A pesar de los avances cient´ıficos, el ca´ncer de mama todav´ıa constituye una de las principales
causas de muerte entre las mujeres en todo el mundo. Dada la gran heterogeneidad entre los
casos, han surgido distintos esquemas de clasificacio´n. La clasificacio´n intr´ınseca de subtipos
moleculares (luminal A, luminal B, HER2-enriquecido y tipo basal) toma en cuenta las carac-
ter´ısticas moleculares y el prono´stico de los tumores, lo que proporciona informacio´n valiosa
para realizar acciones de tratamiento o´ptimas. Adema´s, los recientes avances en biolog´ıa
molecular han proporcionado a los cient´ıficos alta calidad y diversidad de datos o´micos, lo
que abre la posibilidad de crear modelos computacionales para mejorar y validar los sistemas
de subtipos actuales. En este estudio, se creo´ un modelo de Red de Hopfield para el subtipo y
la caracterizacio´n del ca´ncer de mama utilizando datos del repositorio “The Cancer Genome
Atlas”. Aspectos novedosos incluyen el uso de la red como un mecanismo de agrupacio´n
y el uso integrado de varios tipos de datos moleculares (expresio´n gene´nica de ARNm, ex-
presio´n de miARN y variacio´n del nu´mero de copias). Los resultados mostraron capacidades
de agrupamiento para la red, pero aun as´ı, tratar de derivar un modelo biolo´gico de una
Red de Hopfield podr´ıa ser dif´ıcil dado el feno´meno de los atractores espejo (cada grupo
podr´ıa terminar con un opuesto). Como aspecto metodolo´gico, se comparo´ a Hopfield con
los algoritmos de agrupamiento kmeans y OPTICS. El u´ltimo, sorprendentemente, sugiere
la posibilidad de crear un modelo de alta precisio´n que diferencie entre muestras luminales,
enriquecidas con HER2 y basales usando solo 10 genes. El procedimiento de normalizacio´n
de dividir los valores de expresio´n ge´nica entre su nu´mero de copia de gen correspondiente
parece haber contribuido a los resultados. Esto abre la posibilidad de explorar este tipo de
modelos de prediccio´n para implementar pruebas de diagno´stico a un costo menor.
Palabras Clave - Ca´ncer de Mama, Redes Neuronales, Aprendizaje de Ma´quinas, Reconocimiento
de Patrones, Biocomputacio´n.
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Chapter 1
Introduction
1.1 Overview
Cancer is a complex disease of molecular basis with a high mortality rate. Given the great
heterogeneity between cancer cases in terms of genetic behavior and prognosis, some authors
prefer to think of “cancer” as a group of related diseases instead of a single pathological
condition [29, 6, 16]. Such molecular diversity is even present on tumors originating from
the same tissue. For example, breast cancer it is now known to have different molecular
subtypes which the community has agreed upon, namely luminal A, luminal B, HER2-
enriched and basal-like [44, 7]. Current classification schemes will rarely stay static as new
studies might reveal finer-grained classifications for cancer subtypes. Better characterization
of these subtypes at the molecular level will lead to the improvement of diagnostics and
treatments.
Recent advancements in molecular biology have provided scientists with high quality and
high diversity of omic-like data product of processes like sequencing, transcriptome profiling,
copy number quantification and methylation profiling. This has opened the door to new
types of studies which make use of computational models built upon this data. Such models
look to capture patterns in data so our understanding in cancer dynamics can be improved.
Sub-cancer classification has benefited from these approaches, specially from unsupervised
learning techniques like clustering which has revealed the existence of novel cancer subtypes
[43]. There is still room left for trying novel approaches in this regard, specially when making
use of non-conventional clustering algorithms and of data integration techniques for different
molecular data types, which overall, have showed promising results [38, 43].
An unsupervised learning neural network named Hopfield Network has just recently begun
to be explored to model energy landscapes of cellular differentiation [41, 22, 13, 34, 12]. After
being trained with samples data, this model generates a landscape with attractor states which
12
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likely correspond to stable phenotypic states of cellular development, in a manner similar
as Waddington Epigenetic Landscape does [13]. The states could describe either specialized
healthy cells configurations (e.g: epithelial cells, neurons, blood cells), or diseases states as
the different cancer subtypes [22, 13]. Although already been used to explore clustering of
gene expression profiles into cancer subtypes [22], so far, the technique has not yielded a
high quality characterization of breast cancer according to its molecular subtypes (luminal
A, luminal B, HER2-enriched and basal-like). Also the training of these models has been
strictly limited to using gene expression quantification data from microarrays.
On this study, it was explored if it was possible to create a Hopfield Network model for
breast cancer subtyping and characterization. Several types of omic data from samples of
The Cancer Genome Atlas were taken into disposition so different data integration strategies
could be tested. While the initial expectation of finding finer subtypes aside from those
exposed in the literature was rapidly turned down, the model showed capabilities for being
used for clustering purposes. Still, some of its appealing features like the attractors landscape
model should be accompanied of careful interpretation, as it might expose characteristics that
make little sense under a biological context.
As a methodological aspect, Hopfield was compared against other clustering methods like
kmeans and OPTICS (a density-based algorithm similar to dbscan). The last one, in a kind of
unexpected way, showed the possibility of creating a high precision model that differentiates
between luminal, HER2-enriched and basal samples using only a few genes. This opens up
the possibility of exploring these kind of models for implementing diagnostic tests at a lower
cost.
The present thesis document is composed of the following chapters:
• Chapter 1 serves as an introduction to the research problem at hand. Also, the con-
tributions and objectives of this work are stated.
• Chapter 2 contains a theoretical framework with concepts relevant to both the research
problem and applied methods.
• Chapter 3 describes most of the methodological aspects that were followed in order to
fulfill the objectives.
• Chapter 4 shows and discusses the results obtained through experimentation.
• Chapter 5 enumerates some general conclusions, while providing ideas for future work
in the same line of research.
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1.2 Background and Related Work
1.2.1 Cancer Statistics
According to a study published by the American Medical Association, in the year 2015, it
was estimated that 17.5 million cancer cases were diagnosed globally, and there were 8.7
million reported deaths [14]. It was the leading second cause of death behind cardiovascular
diseases. Between 2005 and 2015, incidence of cancer increased by 33% due to factors like
population growth and aging. These statistics reflect the need to invest in cancer control
planning and prevention. This also calls for the development of accurate diagnostics, so
patients can be treated in the most effective way for the particular cancer type/subtype they
have.
In 2015, it is estimated that 2.4 million cases of breast cancer occurred and it was the cause
of death for 523.000 women and 10.000 men [14]. In the context of Costa Rica and according
to the Ministry of Health, in year 2010, breast cancer occupied the first place on mortality
by cancer on women, followed by stomach, colon and cervix cancer [8].
1.2.2 Repositories of Molecular Data
In the latest years there have been great advancements in the bioinformatics community in
terms of production of molecular data and available repositories.
The Gene Expression Omnibus is a public functional genomics data repository supporting
data submissions, mainly gene expression profiles [11]. The Cancer Cell Line Encyclopedia
(CCLE) provides detailed genetic characterization of human cancer cell lines including access
to DNA copy number, gene expression and mutation data [3]. It also includes chemosensi-
tivity responses for several anticancer drugs. The GenBank, the National Institute of Health
(NIH) database of DNA sequences, is constantly being updated with annotated samples and
makes a release every two months [4]. These public repositories bring new opportunities,
encouraging the use of shared resources and scientific reproducibility.
The Cancer Genome Atlas (TCGA) is a project from the National Institute of Health that
began in 2005 as an effort to recognize the genetic mutations that cause cancer. The aim
was to open the door to new studies that could better describe the disease on its molecular
terms [5]. So far, a lot patients have been part of the project (around 11.000 involving 33
different tumor types). The total data in TCGA is around 2.5 petabytes. For each patient it
includes a variety of data sets product of processes like gene expression profiling, copy number
variation profiling, SNP genotyping, genome wide DNA methylation profiling, microRNA
profiling, and exon sequencing. The characterization of each case is comprehensive because
of the possibility of using different molecular data types.
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Just recently, the TCGA was integrated into a bigger initiative named Genomic Data Com-
mons (GDC) [28]. The GDC mainly integrates two repositories: the TCGA and the Thera-
peutically Applicable Research to Generate Effective Therapies database (TARGET)1. Both
databases have been harmonized under the same set of bioinformatics tools, opening the
possibility of establishing comparisons between the two repositories of data. It is expected
that new data will be imported to the GDC.
1.2.3 Clustering Gene Expression Patterns
The clustering of gene expression patterns from microarrays has been of special interest in
the community. It opens up the door for gaining insights on gene co-regulation, and disease
characterization as well [19]. New cancer types have been discovered and studied on this
way.
Pioneering studies on this problem include [15] and [1]. On the former it was possible to
discover the subtypes of acute myeloid leukemia (AML) and acute lymphoblastic leukemia
(ALL) without prior knowledge using self-organizing maps (SOMs). In the second one,
distinct types of diffuse large B-cell lymphoma were identified.
Average-linkage hierarchical clustering was used in [39], on gene expression patterns of breast
cancer derived from cDNA microarrays. It was found that at least two distinct groups
inside luminal type of cancer existed with characteristic gene expression profiles and different
prognosis. The classification of luminal into A and B subtypes appears to initially come from
this study.
There have been also comparative studies of the efficiency of several clustering algorithms
under the context of gene expression clustering.
On [19], authors make note of the complexities associated with gene expression datasets
like the high dimensionality and noise problems. The authors argue that agglomerative
and partitive clustering techniques tend to fall short because of these aspects, and remark
bi-clustering algorithms as an appealing option. An important discussion point is that
clustering methods that don’t need to specify an initial K (number of desired clusters) have
an advantage in terms of exploration without a priori knowledge. But even if they don’t
need to specify K, some of them calculate thresholds for dividing the clusters which might
make little sense in the biological context.
Souto et al performed a comparative study of seven clustering methods and four proximity
measures for the analysis of 35 cancer gene expression microarray datasets [9]. The authors
contributed with a large-scale evaluation which included other clustering methods aside from
the “classic” ones like hierarchical clustering. The evaluated methods included: hierarchi-
1It puts emphasis on cases of childhood cancer.
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cal clustering with single, complete, and average linkage, k-means, mixture of multivariate
Gaussians, spectral clustering and nearest neighbor-based method. It was found that the
finite mixture of Gaussians and k-means gave the best results in terms of revealing the true
structure of the datasets. The authors also note that most of bioinformatics studies involving
clustering make use of hierarchical clustering, probably because of factors like ease of use
and available implementations.
Pirooznia et al compared the efficiency of several classification and clustering algorithms
[32] making use of eight microarray cancer datasets. The evaluated clustering algorithms
were: k-means, density-based clustering, farthest first traversal algorithm and expectation
maximization clustering. Authors reported that the choice of feature selection method, the
number of genes in the gene list, the number of cases (samples) and the noise in the dataset
all influence the quality of the results. Farthest first traversal algorithm obtained the greatest
accuracy.
Hopfield Networks just recently began to be used for clustering cancer samples into cancer
subtypes by Maetschke et al [22].
Overall, most studies have been carried out with microarray data (vs RNA-Seq), non-neural
networks algorithms and the number of used samples rarely overpass 100.
1.2.4 Hopfield Networks Usage in Gene Expression Landscapes
Hopfield Networks (HNs), recurrent neural networks that model associative memory [17, 23],
have been used before to model attractor landscapes from gene expression data. The main
idea has been to construct models that have the capacity of mirroring the dynamics of the
underlying gene regulatory network when converging towards a certain stable state from the
cell. Computing units in the network correspond to genes, and the weights between units
represent how much the expression of genes affect each other.
The gene expression levels from a cell tend to converge to stable states of minimum energy as
the cell differentiates into more specialized states [49] (see figure 1.1). In the same way, a HN
can associate an input pattern with the most resembling stored pattern, hence converging
in some way.
In [13], HNs are used to model the epigenetic landscape of cellular development for several
biological processes in a manner similar to Conrad Waddington’s model (which traces the
evolution of cells from a pluripotent state to a committed state). The authors used gene
expression data across different states of development in time. Using HNs, they identified
genes and transcription factors that drive cell-fate transitions. A similar approach has been
explored, but putting emphasis on modeling the progression of several diseases like Parkin-
son’s disease, glioma and colorectal cancer [12]. Each attractor in the HN likely corresponds
to a specific stage in the disease.
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Figure 1.1: After being trained, a Hopfield Network can be used to model an energy landscape
of cellular differentiation. Attractor states (stored patterns) at the bottom of the landscape
correspond to stable phenotypic cell configurations of minimum energy (gene expression
levels that induce the cell to either healthy or disease states). Transition states could be also
present at peaks or as local minima. Source of image: [49].
Szedlak et al explored the asymmetric Hopfield model for generating attractor states for
cancer gene expression data [41]. Once trained, the authors proposed an analysis on the
network’s weighted graph for detecting strongly connected cluster of nodes that have a
significant impact on signaling in the gene network. In this way, candidate sets of proteins
can be detected for intelligent therapeutic interventions.
Koulakov and Lazebnik used Hopfield Networks to support a model for cell fusion [21]. Each
cell has a Hopfield Network with several attractors, each one corresponding to a stable cell
phenotype. The fusion of two different cells might give rise to spurious attractor states which
might turn the cell cancerous.
Pusuluri et al also study [34, 33] how recurrent neural networks can be used to model energy
landscapes of biological processes with a given set of attractors. He puts particular attention
to the properties of the generated landscapes instead of concentrating on other previously
analyzed aspects of the networks like storage capacity and stability of patterns. Hopfield
networks, and a similar model (Kanter and Sompolinsky) were used in the study.
1.2.5 Clustering Cases from Subtypes of Breast Cancer
The study from Sorlie et al [39] proves to be seminal in the area of breast cancer char-
acterization using clustering algorithms. Using hierarchical clustering, they managed to
detect several cancer subtypes inside the luminal one. In [46], a similar clustering approach
was effectuated which resulted into two well defined clusters, which members differed in
ER states and lymphocytic infiltration. Sotiriou et al also used hierarchical clustering in a
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population-based study, giving as a result two major subgroups based on their ER status
[40]. It correlated well with basal and luminal characteristics.
A comprehensive study using different data platforms from The Cancer Genome Atlas rein-
forces the fact that the four breast molecular subtypes (luminal A, luminal B, HER2-enriched
and basal-like) are well established [44] and each possesses their own characteristics for each
of the molecular subtypes. The authors claims that this reinforces the hypothesis that much
of the clinically observable heterogeneity occurs within these major subtypes.
In [43] known breast cancer subgroups were detected. The authors made use of an integrated
data approach of four platforms (gene messenger RNA expression, DNA-methylation, copy-
number variation and microRNA expression) and clustered cases of 4,434 samples from The
Cancer Genome Atlas across 19 cancer types. The technique involved the selection of prin-
cipal components from each data type and then an early (concatenation-based) integration
of data was performed. Then DBSCAN (Density-Based Algorithm for Discovering Clus-
ters) was applied. Subtype analysis of the 563 breast cancer cases revealed five clusters
that mostly correspond to the know molecular subtypes. However luminal A was splitted
into two different clusters and some cases of basal-type were put together with the ones of
HER2-type into a single cluster. See figure 1.2. This thesis work took a different approach
for data integration, although it used the same molecular data types (except methylation
values).
Figure 1.2: Clustering results from [43]. The method managed to divide luminal A cases
into two clusters, but was unable to correctly separate HER2-type cases from basal.
The work from Maetschke et al [22] is the one that most resembles this one in terms of
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objectives and methodology. They suggested using Hopfield Networks specifically for char-
acterizing cancer subtypes as attractor states in a Hopfield Network. They also introduced
a pruning method for discarding genes which would contribute little to the overall perfor-
mance of the model. The authors used the microarray datasets proposed by Wang et al
[47] and Souto et al [9] for training the networks. The ones that were trained using breast
cancer datasets did not particularly show good results. This work differs in the sense that
was specifically aimed at breast cancer characterization and contemplated using several omic
types (not just gene mRNA expression) for improving the accuracy of the model. Used data
was from the TCGA and, for validation purposes, prelabeled using the four main molecular
subtypes of breast cancer.
1.3 Problem Definition
From the biological point of view, breast cancer heterogeneity constitutes the main prob-
lem. Aspects like diagnostics, prognosis and effectiveness of treatments are all affected by
the molecular characteristics of tumors. This problem can be approached by building a
computational model of breast cancer subtyping.
Given a dataset D with multi-omic data of n cancer samples, the problem of building a
model for cancer subtyping can be formally defined as a type of clustering problem.
A clustering C for D is a partition of the n patients into mutually disjoint subsets C1, C2,
. . ., CK called clusters. Formally the following properties must hold [25]:
C = {C1, C2, . . . , CK}, Ck1 ∩ Ck2 = ∅ with k1, k2 ∈ {1, . . . , K}, k1 6= k2 and
K⋃
k=1
Ck = D
Also |Ck| > 0, k ∈ {1, . . . , K}. In other words, empty clusters are not allowed.
There is a function subtype : D → L which associates a patient with a label for his/her
cancer subtype. L = {l1, l2, . . . , lm} is the set of possible labels known a priori for each
known cancer subtype. In the context of breast cancer this set corresponds to:
L = {luminalA, luminalB, basal, her2}
.
These labels are know a priori for each patient.
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A reference clustering C ′ can be defined as C ′ = {C ′1, C ′2, . . . , C ′m}. Each cluster C ′k is defined
as C ′k = {pi ∈ D, i ∈ {1, . . . , n}|subtype(pi) = lk}.
There is also a numerical function f that quantifies how much two clusterings differ accord-
ing to some criteria. The problem consists in finding a clustering C such that f(C,C ′) is
optimized as much as possible. The function f chosen for this study was the Adjusted Rand
Index (ARI) which ranges from -1 to 1. Higher values denote better agreement between the
clusterings in terms of precision and recall.
From the statistical point of view, the problem can be seen as a multivariate analysis where
thousands of variables (in this case transcript levels of genes) are involved per observation,
and there is also the possibility of using other data views like copy number variation for
deriving new features.
1.4 Hypothesis
Through the use of multi-omic data from the TCGA and a hebbian learning scheme, is
possible to create a Hopfield Network model for breast cancer subtyping and characterization.
This model will either differentiate between the main four molecular subtypes of breast
cancer, or will find a finer classification inside these.
1.5 Justification
Under this context, having a computational model that accurately clusters patient cases
would help in the characterization and discovery of subtypes of breast cancer. Hopfield
Networks serve well both purposes. After being trained, each attractor state in the net-
work encodes a binary state for each gene of interest (+1 for an highly expressed gene, -1
otherwise). An attractor defines a cluster for those cases that are converging to it.
Characterization means that key regulator genes and the dynamics between them could
be better understood for each detected subtype (cluster) in the model. In other words, the
attractor states of the model could aid in the identification of candidate biomarkers for prog-
nosis and treatment, as such states would encode the different breast cancer configurations
for the gene regulatory network. The candidate biomarkers would need to be validated later
in vitro by experts in the area.
The model has also the potential to reveal new cancer subtypes. The unsupervised nature
of the Hopfield Network model does not require prior knowledge, nor an initial number of
clusters (k), and the attractor states are discovered as the network is trained. A set of
1.5. JUSTIFICATION 21
attractor states where a certain subtype of breast cancer cases are concentrated (e.g basal-
like cases), might reveal a finer subdivision inside the subtype. This could be later validated
using tools like survival analysis, which might reveal significant differences for the prognosis
of the subtypes.
If compared to other classical approaches for clustering, there are a number of reasons why
using Hopfield Networks represents an innovative and appealing option:
• Biological interpretation: Hopfield Networks associative memory capabilities can
be used to model an energy landscape with attractor states of minimum energy at the
bottom. The landscape metaphor has been used before by the biological community,
specially when referring to the cellular differentiation process and the progression of
diseases [49]. The cell’s gene regulatory network, when adjusting the levels of tran-
scripts of genes, highly resembles a dynamical system that seeks to converge to a stable
state as time passes. Hopfield Networks, when recalling a stored pattern mimic exactly
this behavior, as the input pattern converges to the state of the nearest attractor in
the landscape.
• No need of prior knowledge: Hopfield Networks don’t need an initial k number of
clusters. Attractors are discovered based on the characteristics of the training data.
This proves to be useful when looking for potential new cancer subtypes.
• An unified clustering-classification framework: Hopfield Networks separate the
learning process (adjusting the weights of links between units) from the recalling pro-
cess (associating an input with a stored attractor). The recalling process is first effectu-
ated on the training samples for clustering purposes. Then when the generated model
is validated and understood, recalling could be used on new samples for classification
purposes.
• Algorithmically simple: The coding effort for implementing a Hopfield Network is
not high. Between 35 and 50 lines of code are needed in a language like R which is
optimized for data manipulation.
• Other analysis: It is possible to use visualization methods like the one in [22] for
displaying the energy landscape associated with the network. This intuitively gives
a measure of how far are cases from converging to their associated attractors. It is
also possible to trace the convergence route from each case to their attractor, hence
revealing the evolution of the gene regulatory network as it converges to a stable state
[12]. Other properties of the attractors like their basin of attraction and density have
been studied [33].
This study introduced some novel aspects from the methodological standpoint:
• The use of a Hopfield Network for clustering breast cancer cases into its four main
molecular classes: luminal A, luminal B, basal-like and HER2-enriched. Other studies
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involving Hopfield Networks are not fully focused on breast cancer and use other simpler
classification schemes for validation.
• Testing new multi-omic approaches for data integration using three different views of
data: gene (mRNA) expression, miRNA expression and copy number variation. Most
studies are limited to the usage of gene (mRNA) expression only.
• A high quantity of cases from The Cancer Genome Atlas was used (around 1000).
Most studies limit to smaller datasets (100 cases at most).
Other factors that also motivated and contributed to this research effort are the proliferation
of data science techniques, the improvement of latest generation genomic and sequencing
technologies and the collaborative effort that is being held by the PRIS-Lab2 and the LQT3,
which played a key role for this project’s definition and development.
The PRIS-Lab BEND team, in collaboration with other laboratories or research centers, is
fully devoted to research on the field of Computational Biology. Research interests include:
cell tracking on light field microscopy, chemosensitivity prediction, computational structural
molecular biology, recognition of patterns in optical spectroscopy, among others. According
to the National Institute of Health, the field of Computational Biology seeks to use math-
ematical and computational methods to answer theoretical and experimental questions in
the sciences of life, in contrast with Bioinformatics which is more concerned about using
informatics principles to make biological data more understandable and useful [30].
1.6 Objectives
1.6.1 Main Objective
Use a Hopfield Network model built from multi-omic data of the TCGA for clustering cases
from different subtypes of breast cancer.
1.6.2 Specific Objectives
1. Create the necessary software infrastructure for loading and preprocessing the data
from the TCGA.
2. Create the necessary software infrastructure for training and visualizing a Hopfield
model.
2Pattern Recognition and Intelligent Systems Laboratory, School of Electrical Engineering, University of
Costa Rica.
3Tumoral Chemosensibility Laboratory, Microbiology Department, University of Costa Rica.
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3. Design and implement procedures for generating either standalone4 or integrated datasets
that make use of the gene (mRNA) expression, miRNA expression and copy number
variation data views.
4. Run experiments varying the generated datasets, measure the effectiveness of the
trained models (while comparing with at least two other algorithms) and analyze the
results.
1.6.3 Scope
• The used data integration approaches were “early”. This means new datasets were
derived before performing the training procedure.
• Feature selection played a crucial role as the total number of features exceeded the
60000. Only protein coding genes were used and not more than 100 were chosen for
creating a model.
• Even if the proposed approach for training the Hopfield model was general enough to
be applied to data of other cancer types, the study was exclusively focused on breast
cancer cases from the TCGA.
• Cases from the TCGA that did not have all the necessary data views (gene mRNA
expression, miRNA expression, copy number variation) were excluded from the study.
• Having an initial subcancer PAM50 label for the used cases is a prerequisite condi-
tion for validating the created model. Otherwise, cases which did not possess this
information were excluded from the study.
• It was not contemplated in the scope of the study creating a R package or similar.
• All analysis were executed in silico.
1.6.4 Deliverables
The following table describes all the deliverables for this project. Please refer to the specific
objectives enumerated in the previous section.
4Standalone refers on this case to a dataset which contains information from a single type of data view.
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Objective Activities Deliverable(s)
Specific Objective
1
Implement functions in R. Source code in R for loading
and preprocessing the data
from the TCGA.
Specific Objective
2
Implement functions in R. Source code in R for train-
ing and visualizing a Hop-
field model.
Specific Objective
3
Define and implement procedures for
generating either standalone or inte-
grated datasets.
Source code in R for creat-
ing the datasets.
Specific Objective
4
Run experiments and collect results
data.
Results from experiments
and written analysis.
Chapter 2
Theoretical Framework
2.1 The Problem of Cancer
Cancer has been a mainstream human race health problem for years. It mainly causes an
erratic behavior on the cell natural mechanisms of division and programmed death (apopto-
sis), which in turn triggers abnormal cell growth and proliferation through the tissues [29].
This process gives rise to the formation and development of masses of cells called tumors.
It might prove lethal, specially if these enter an advanced state where they spread towards
other organs different from the one of origin, a process called metastasis.
Carcinogenesis, the process of cancer formation, is mainly the result of mutations in somatic
cells1. Some cancer-causing mutations are due to environmental factors and exposure to
carcinogenic substances. Others are the result of errors during DNA replication and lack
of proper DNA repairing processes. Given its genetic nature, the susceptibility to develop
cancer varies from person to person. Cells can also become cancerous by being infected by
certain viruses (called oncoviruses).
When a cell becomes cancerous, the gene expression levels of certain genes become altered
and differ from that of a normal (differentiated) cell. There are mainly 2 types of genes
that affect cancer. Oncogenes and tumor-suppressor genes [18, 16]. Oncogenes are mutated
forms of certain genes that usually play some role in cell division or growth. By themselves,
these genes (called proto-oncogenes in their normal forms), are necessary for the correct
functioning of the cell. However, in their oncogene forms, they are cancer-producing agents.
This is normally reflected in terms of proteins with hyperactive behaviors or overproduction
of proteins associated with the oncogenes. Proto-oncogenes usually code for: growth factors,
cell surface receptors, transcription factors and signal transmission proteins (like kinases).
1Cancer could start by other means like the silencing of key genes product of epigenetic modifications
like methylation [42].
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On other hand, tumor-suppressor genes usually suppress uncontrolled cell division. They
have a protective function, that when inactivated via mutations, might give rise to tumors.
It is usually necessary the combination of mutations on both oncogenes and tumor-suppressor
genes to give rise to cancer. Given the important role they play, some oncogenes are used as
biomarkers or are targeted by drugs to inhibit cancer progression.
Several molecular processes also contribute to carcinogenesis or irregularities in the gene
expression levels of cancer cells:
• Modifications of the karyotype (number and appearance of the cell chromosomes),
might lead the cell to an aneuploid state which contributes to cancer progression [37].
Some regions (or even complete chromosomes) might be copied or deleted.
• Expression of miRNAs play a regulatory role for other genes [31]. The miRNAs are
a type of small non-coding RNAs that bind to the transcripts of other genes, thus
preventing their translation to proteins.
• Methylation is an epigenetic process that also plays a role silencing certain key genes
[42]. Tumor-suppressor genes might be affected in this way.
Cancer types can be classified by tissue of origin, e.g. stomach, colon, breast, among others.
But finer classifications could exist inside these types.
2.2 Breast Cancer Classification
Breast cancer develops from breast tissue. Breast tissue includes the one from the lobules
(glands that make milk), the ducts (thin tubes that carry the milk from the lobules to the
nipples), lymph nodes and blood vessels. Breast cancer usually originates from the tissue
of the ducts (ductal carcinoma) or from the lobules (lobular carcinoma), but could also
originate from other places. If the abnormal cells haven’t spread to neighboring tissues, then
it is said that the cancer is in situ. Otherwise it is called breast invasive carcinoma [27].
Breast cancer is the most common cancer on woman. It is estimated that it affects about
12% women worldwide [24].
Breast cancers can be categorized using a variety of criteria. Every one of them provides
some input that can be used by oncologist to determine the best course of action when
treating a patient:
1. Histopathology: refers to an assessment made by microscopic observation of tissue.
As described previously, common classifications in this regard are ductal carcinoma
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and lobular carcinoma (depending of the primary site of the tumor). Tumors in the
same histopathological category can follow different clinical courses and show different
responses to the same therapy [15, 6]. This reveals the necessity of other means of
classification.
2. Grade: indicates how much have cancer cells lose their differentiated state in com-
parison to normal cells of the tissue. Common descriptions are well differentiated
(low-grade), moderately differentiated (intermediate-grade) and poorly differentiated
(high-grade). The higher the grade, the worse the prognosis. It is also expected that
higher grade tumors will differ in a greater way from normal cells in their gene expres-
sion levels.
3. Stage: the relative size of the tumor and how much has spread to neighboring tissues.
Stage 0 refers to in situ state (benign tumor). Stages 1-3 indicate an invasive state
and the higher the number, the greater the size of the tumor and dispersion within
the breast or lymph nodes. Stage 4 indicates metastatic state. Again, higher numbers
have associated a less favorable prognosis.
4. Receptor status: in breast cancer cells there are 3 receptors of particular importance:
estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth fac-
tor receptor 2 (HER2). Their presence or absence is currently an important input for
deciding the most appropriate therapy. For example, estrogen receptor positive cancer
cells (ER+) need estrogen in order to growth, so they can be treated in a way that
specifically target estrogen levels. Triple negative cancers (ER-/PR-/HER2-) currently
have the worse prognosis because of the lack of targeted treatments.
5. Molecular subtypes: these types give an insight into the receptor status along with
tumor grade and prognosis [20]. Novel approaches might categorize cases into one of
the 4 main classes:
• Luminal A: Tend to be estrogen receptor-positive (ER+), HER2 receptor-negative
(HER2-) and tumor grade 1 or 2. They also tend to have the best prognosis and
can be treated with hormone therapy. Most breast tumors are Luminal A.
• Luminal B: Tend to be estrogen receptor-positive (ER+), may be HER2 negative
or positive (HER2-/HER2+). Have poorer prognosis than luminal A reflected in
aspects like a higher grade and stage.
• Basal-like: The majority of these cases are triple negative (ER-/PR-/HER2-). Of
all subtypes, these have the poorer prognosis and tend to be aggressive. These
are usually treated with surgery, radiation therapy and chemotherapy.
• HER2-enriched: Most of them (70%) are HER2+. These also tend to be ER- and
PR- and have a poorer tumor grade. HER2 type breast cancers can be treated
with anti-HER2 drugs like trastuzumab (Herceptin).
There has been great interest in characterizing these subtypes at the molecular level
[44].
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2.3 Pattern Recognition and Artificial Neural Networks
Pattern recognition is the act of taking in raw data and taking an action based on the category
of that pattern [10]. A common pipeline followed on the Pattern Recognition paradigm
involves the steps of data preprocessing, feature extraction, and then, classification (usually
performed by some previously trained model). A lot of other challenges and sub-problems
are usually present when building pattern recognition systems, among these: noise in the
data, overfitting, high dimensionality, use of prior knowledge, missing features and others.
If the samples from the training data possess labels that are used by the learning algorithm
then the process is said to be supervised. Otherwise it is said to be unsupervised. Unsuper-
vised learning is popular for performing exploratory data analysis where a clear structure of
data is not known beforehand. It serves well for finding candidate categories for the data
and identifying features of interest [10]. Major departures from expected characteristics (like
the discovery of subclasses) can be found when using unsupervised learning methods.
Clustering is probably the most common task under unsupervised learning. The idea behind
consists of finding a partition of a set of entities, such that similar ones are combined in
the same clusters, while dissimilar entities end up on different clusters [26]. The concept
of similarity might vary entirely from one clustering algorithm/methodology to another.
Hence, the problem of finding the best clustering algorithm for a given problem is not
straightforward.
Artificial neural networks are computing systems that seek to mimic the computational
capabilities present in the biological neurons [36]. These systems are used for both supervised
and unsupervised learning tasks. An artificial neural network has a collection of connected
computation units. These connections (usually weighted) mark the directionality of signals
between computing units. If the amount of input signal overpass some threshold, then the
given unit triggers a signal that is sent to other connected units. Flows of signals in this
fashion (along with the correct weights between units) allow the computation of functions.
Learning a function with an artificial network usually involves adjusting these weights.
One of the categorizations used for artificial neural networks takes into account how the
computation units are connected. The most common type, feed-forward neural networks
don’t posses cycles between units and their connections. On the other hand, recurrent
neural networks might have connections between units that form cycles.
2.4 Hopfield Networks
A Hopfield network is a type of recurrent neural network with n computing units, where n
is also the number of dimensions of the data. Each computing unit acts as an input and
2.4. HOPFIELD NETWORKS 29
output unit, which results in a matrix W of approximately n2/2 weighted links representing
the network (basically, a complete undirected graph). See figure 2.1.
Figure 2.1: A Hopfield Network is a full, undirected graph. In other words the weight wnm is
equal to the weight wmn. This property is necessary for the network to converge to a stable
state when “recalling” a stored pattern from a input pattern.
Two popular approaches for calculating the weights between links are Hebbian learning and
Pearson correlation indexes. The network can be trained using Hebbian learning with the
following formula:
W =
1
m
m∑
k
pkp
T
k − I (2.1)
Here, m is the number of patterns used to train the network. The formula calculates the
sum over the outer products of the pattern vectors pk, then normalizes values and sets the
diagonal with zero values. The result, the matrix W , contains the numerical values of the
network links, where Wij is the weight of link connecting computing unit i to computing
unit j.
On the other hand. It is possible calculate the weights of the matrix W as Pearson correlation
indexes. The entry Wij corresponds to the Pearson correlation index between the values of
feature i with that of feature j.
After being trained, the network can be used to “recall”. This means that given a new
input pattern p, the network can associate the pattern p with the closest pattern q that
it remembers. This ability to reconstruct stored patterns from similar input is the reason
Hopfield networks are considered a way of implementing associative memory. Input patterns
associated with the same stored pattern form a cluster of similar entities.
The “recall” phase for a input pattern works as follow. The process is divided into different
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time steps t. At any time step t′, each computing unit has a binary state si ∈ {−1, 1},
i ∈ 1, . . . , n. The states for the next time step are calculated as follows:
s
(t′+1)
i = sgn
(
n∑
j
Wijs
(t′)
i
)
(2.2)
The sgn is defined in the following way:
sgn(x) =
{
+1 x > 0
−1 x ≤ 0 (2.3)
Given an input pattern p = (p1, . . . , pn) for the “recall” phase, the initial state of the network
is calculated as s0 = (sgn(p1), . . . , sgn(pn)). Then, equation 2.2 is run for the t iterations.
It is guaranteed that if t→∞, then the state of the network will converge to a stable state
with minimum energy.
If all computing units are updated simultaneously (like described previously) then the model
it is said to be synchronous. Otherwise, if computing units are updated one at a time then
the model is asynchronous. Some authors argue that the asynchronous model better mirrors
the biological nature of how neurons work.
Chapter 3
Methods
The present chapter purpose is to fully describe the methods that were followed in order to
fulfill each one of the specific objectives.
3.1 Computing Platform
As a methodological aspect relevant across all specific objectives, it is stated that the soft-
ware platform used for running algorithms, visualizing data and performing analysis was
exclusively the R Statistical Computing Environment version 3.4.3 (2017-11-30) – “Kite-
Eating Tree”. It is also worth mentioning that the IDE RStudio (Version 1.1.414) was used
in order to facilitate the coding process. Its debugging and documentation features were
worth exploring and contributed to the development work.
3.1.1 Used Packages
Relevant used R packages1 (and their respective versions) are listed below:
• TCGAbiolinks (2.6.12) - An R/Bioconductor package for integrative analysis
with GDC data: Provides facilities for querying and downloading data from the
Genomic Data Commons repository. It also includes other convenient features, namely,
the capacity of loading downloaded data as R data frames (table-like data structures)
and the access to premade datasets with annotation labels for the TCGA patients.
1The Bioconductor version used was 3.6. Every Bioconductor package is also a R package, but it might
follow a different release cycle that differs from the normal R scheduled releases.
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• CNTools (1.34.0) - Convert segment data into a region by sample matrix to
allow for other high level computational analyses: This Bioconductor package
allows transforming copy number per segment data to a copy number per gene matrix.
This is important in terms of compatibility with other data types, such as expression
data which is given in terms of genes (not regions).
• Matrix (1.2-12) - Sparse and Dense Matrix Classes and Methods: This package
facilitates more efficient representations and operations for matrix structures than the
native ones from R.
• scatterplot3d (0.3-41) - 3D Scatter Plot and rgl (0.99.16) - 3D Visualization
Using OpenGL: Used for supporting and enhancing the visualization of data, specif-
ically after performing Principal Component Analysis.
• gglot2 (2.2.1) - Create Elegant Data Visualisations Using the Grammar of
Graphics: Plotting library for generating the graphics in the “Results” Chapter.
• ClusterR (1.1.1) - Gaussian Mixture Models, K-Means, Mini-Batch-Kmeans
and K-Medoids Clustering: Mainly used because it provides functions for calcu-
lating clustering validation metrics like Rand Index, Adjusted Rand Index, Precision,
Recall, among others.
• dbscan (1.1-2) - Density Based Clustering of Applications with Noise (DB-
SCAN) and Related: Contains implementations for the DBSCAN and OPTICS
clustering algorithms. OPTICS was used in the experimental runs in order to have a
reference point, hence not relying exclusively on the Hopfield Network’s performance
for drawing conclusions about multi-omic data usage.
• FactoMineR (1.41) - Multivariate Exploratory Data Analysis and Data Min-
ing: Used for its more sophisticated PCA plotting functions.
3.2 Source Code Organization
R is an interpreted language. As such it provides very good prototyping capabilities (line
by line execution, relaxed typing system, writing complex tasks with a minimum of code).
However, the developer must beware relying too much on these features, as the code can
easily reach an unmaintainable state and have poor modularization qualities. These reasons
suggested the necessity of organizing the code among different project units and source files.
This basic organization can be easily reused for other data-intensive kind of projects.
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Figure 3.1: Projects organization and dependencies.
3.2.1 Projects
Projects provide the highest level of organization for source code. These reflect the following
processes:
1. Data acquisition, cleaning and tidy dataset generation: This project contains all code
related to using the GDC client tool for downloading the required data, cleaning it and
generating datasets that are ready to be processed by algorithms.
2. Algorithmic support: Contains code implementing machine learning, normalization
and feature selection algorithms.
3. Experiments execution and results generation: Provides the infrastructure for running
experiments in an efficient and organized way. This project depends on “Algorithmic
support” and generates results datasets that act as the input for the “Reports” project.
4. Reports: Generates graphics summarizing the results obtained by previously running
the experiments.
As can be seen, these projects constitute a natural organization of code that reflects the
pipeline through which data is transmitted from one unit of organization to another. See
figure 3.1.
Each project follows the basic folder structure showed on figure 3.2.
In the following sections, more detail is provided about the different processes supported by
these project entities.
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Figure 3.2: Basic project structure. a) .Rproj file contains basic configuration for the project.
b) logs folder collects the log files generated after the main.R script is executed. c) scripts
folder contains all .R files associated with this project. There are two mandatory files on
most of the projects: init.R for installing missing package dependencies and main.R which
launches the process associated with the project in order to generate the output files. d) A
git repository is also defined at this level for source control purposes.
3.3 Data Download and Tidy Dataset Generation
3.3.1 About The Cancer Genome Atlas Data Source
The Cancer Genome Atlas is now part of the Genomic Data Commons project. In summary,
the Genomic Data Commons is a property oriented graph database which organizes a great
diversity of files. Information could be classified as genomic, clinical or biospecimen depend-
ing of its nature. Genomic data categories include: sequencing data, copy number variation,
DNA methylation, simple nucleotide variation, genomic profiling and transcriptome profiling.
Each data category uses its own data file formats (for example .tsv for transcriptome profiling
and .bam for aligned reads). Also each data category can be further subdivided into different
data types. Transcriptome profiling has three subtypes e.g: gene (mRNA) expression, exon
expression and miRNA expression. For this study three data types for each cancer case were
used: gene (mRNA) expression and miRNA expression (both belonging to the transcriptome
profiling category), and the masked copy number segment data type (which belongs to the
copy number variation category).
Some data categories and types are showed in the table 3.1, just to emphasize the difference
between them and the great diversity of multi-omic data available in the Genomic Data
Commons repository.
3.3.2 Data Download
The files from the Genomic Data Commons repository can be accessed in mainly three ways:
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Data Type Data Category File Extension Experimental Strategy
Gene Expression
Quantification
Transcriptome
Profiling
.tsv RNA-Seq
miRNA Expres-
sion Quantifica-
tion
Transcriptome
Profiling
.tsv miRNA-Seq
Masked Copy
Number Segment
Copy Number
Variation
.tsv Genotyping Array / Tar-
geted Sequencing
Methylation Beta
Value
DNA Methylation .tsv Methylation Array
Aligned Reads Sequencing Data .bam RNA-Seq / miRNA-Seq
Raw Simple So-
matic Mutation
Simple Nucleotide
Variation
.vcf Various
Simple Germline
Variation
Simple Nucleotide
Variation
.vcf Various
Table 3.1: Examples of data types supported by the6 Genomic Data Commons repository.
1. Using the GDC Data Portal: files to download are selected using a web user interface
in a style similar to e-shopping. See https://portal.gdc.cancer.gov/.
2. Using the GDC Data Transfer Tool: a standard client-based mechanism supporting
high performance data downloads and submission.
3. Directly consuming a public RESTful API.
The first option was immediately discarded, as some automated way of downloading data is
much more preferred over the manual selection of files (at least for the volume intended to
be downloaded which summed up to 3000 files approximately). There was one file per data
type per patient.
Given that the implementation platform for this project was R, two Bioconductor packages
that consume the GDC RESTful API seemed to be good options for downloading and prepro-
cessing the necessary data. These were the “TCGABiolinks” and “GenomicDataCommons”
packages. The second one is currently maintained by an official member of the National
Institute of Health and its API really mirrors the web service structure and the resources
it exposes, so it was considered as the first implementation option. However, this package
lacked a crucial feature, that was, the capacity of merging all the files for the same data
category into a single R dataset.
On the other hand, the “TCGABiolinks” package supported loading the data more easily
as R/Bioconductor objects and in general had better preprocessing capabilities. Another
relevant feature of this package (even if not used for this project), is the capacity of populating
“SummarizedExperiment” Bioconductor objects from the downloaded data. These possess
facilities for organizing metadata of patients and features (genes).
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After these considerations, the “TCGABiolinks” package was used in conjunction with the
GDC Data Transfer Tool (which can be invoked from R). Basically three steps are required
by the package to download a group of files and merging them into a single dataset. These
are:
1. Create a GDCQuery object with the proper parameters, like in the following example:
GDCquery( p r o j e c t = ”TCGA−BRCA” ,
data . category = ” Transcriptome P r o f i l i n g ” ,
data . type = ”Gene Express ion Q ua n t i f i c a t i o n ” ,
workflow . type = ”HTSeq − FPKM” )
The call to the function GDCquery returns an object containing metadata of the
files to download (size, data category and type, among other details) but it does not
execute the actual download process. This is useful, as some rechecking can be done,
with the possibility of excluding some files from the final download list. The previ-
ous query selects cases from the “TCGA-BRCA” (that is Breast Invasive Carcinoma)
group, from which it retrieves gene (mRNA) expression quantification files (belonging
to the transcriptome profiling category) and which are normalized using the FPKM
(Fragments Per Kilobase) procedure [45].
Using raw RNA-Seq reads is not recommended as the gene length (number of base
pairs) might introduce a bias. Longer genes capture more reads which does not nec-
essarily translate in higher transcription rates [35]. The FPKM normalizes expression
rates according to each gene’s length.
2. Call the GDCdownload function with the GDCQuery object:
GDCdownload( query = query . object , method = ” c l i e n t ” )
The parameter “method = client” indicates that the “gdc-client.exe” executable is used
for performing the download (which can be previously acquired through the GDC’s
website). Using the client application is in general a more efficient and robust method
for downloading a high quantity of files. The default method uses direct HTTP requests
to the REST service which is better suited for a small amount of files.
3. Call the GDCprepare function with the GDCQuery object:
data <− GDCprepare ( query = query . object ,
summarizedExperiment = FALSE)
This function will look for the previously downloaded files and will merge them into a
single R data frame (which still requires some cleaning described in the next section).
The resulting dataset will of course vary in their variables depending of the processed
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data type. However all share the same observations (breast cancer patients samples in
this case).
The previous process was repeated for each one of the three kinds of genomic data types that
were used: gene (mRNA) expression, miRNA expression and masked copy number segment,
varying the “GDCQuery” accordingly.
3.3.3 Tidy Dataset Generation
The generated sets still required some extra processing before they are ready to be used.
The process of “tidying” refers to cleaning the data from unwanted values and restructuring
the observations and variables so they are easy to manipulate [48]. This process is somewhat
similar to data normalization on relational databases. Fortunately the tidying process was
minimum. This is described in the following sections.
Previous Steps to Generation of Tidy Sets
As a prerequisite to the process of generating the tidy sets for each one of the molecular
types used, it was necessary to generate two auxiliary datasets.
1. The first of them contains the breast cancer type labels for each sample, that is the
type of breast cancer for each patient (luminal A, luminal B, HER2 or basal). The
package “TCGABiolinks” provides a function PanCancerAtlas subtypes that re-
turns a predefined dataset with this information. A set of filters were applied to the
returned set.
(a) First, filtering the cases to the TCGA-BRCA group of samples.
(b) Second, restricting the type of tissues to solid tumors. This must be deduced
from the structure of the TCGA bar codes. These are uniques identifiers used
to recognize one sample from another inside the TCGA database. They codify
several information pieces separated by hyphen characters. One of these segments
indicates the type of tissue. Other type of tissues include “normal-like”, whose
most of their cells are still in their normal differentiated states. Some patients
have samples for both normal and solid tumor states, but only the latter ones
were kept.
This dataset was used for the generation of other tidy sets and for clustering validation
purposes as well.
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2. The second auxiliary set contains the list of all the protein coding genes. This can
be generated by a custom tool (genome browser from the www.ensembl.org website).
This set was used for filtering purposes.
Gene (mRNA) Expression Data
Taking a quick look at how data was organized, it first came to attention that the data
appeared to be transposed. That is, patients corresponded to columns and genes to rows.
For the ease of treatment it was kept in that way unless some function required the opposite
format. This clarification is necessary, as the variables in this study might be referred as the
dataset rows (instead of columns) in the following sections. This also applies to the columns,
which might be referred as the cases.
For the gene (mRNA) expression data the following changes were applied:
1. Assigning values of the first column to be the “row names” of the dataset. These
values corresponded to gene ids as they appear in the Ensembl database. After this,
the column was eliminated.
2. Bar codes were cut out to the first 16 characters. The other bar code segments con-
tained details that were not useful for the study.
3. Patients for whose breast cancer subtype are not in the “Labels” auxiliary dataset are
removed.
4. The second auxiliary set was used to limit the genes to only protein coding genes
(around 20000). This constitutes a 3:1 ratio reduction, as the original number of genes
is around 60000. The total group of genes include pseudo-genes or genes that produce
some kind of non-coding RNA.
See figure 3.3 for the resulting dataset.
miRNA Expression Data
The nature of miRNA Expression data is very similar to the more conventional gene (mRNA)
expression data (a numeric matrix of cases versus genes). The primordial difference is that
GDC files related to this type of data contain both raw and normalized values (with the
reads per million mapped reads procedure, see figure 3.4), whereas the gene expression data
divides both types of values into different kind of files (hence only files for the normalized
ones were retrieved). The tidy dataset generation procedure was as follows:
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Figure 3.3: Resulting gene expression dataset which contains Fragments Per Kilobase of
transcript per Million mapped reads.
Figure 3.4: Raw miRNA expression data (as generated by GDCPrepare function). Each
sample contains three associated columns: read count, read per million miRNA
mapped and cross-mapped. Only one sample’s data is showed because of space limi-
tations.
1. All columns with raw count values and cross mapped flags were eliminated.
2. The remaining ones were renamed so they only contained the TCGA bar code for the
samples.
3. Bar codes were cut out to the first 16 characters.
4. Patients for whose breast cancer subtype are not in the “Labels” auxiliary dataset are
removed.
See figure 3.5 for the resulting dataset.
Copy Number Data
TCGA Copy number data is organized into genomic segments. That is, the dataset is
composed of one record per affected region (i.e showing copy number variation), potentially
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Figure 3.5: Resulting miRNA dataset which only contains read per millions mapped reads
values.
Figure 3.6: TCGA copy number segment raw data (as generated by GDCPrepare function).
Sample corresponds to the sample’s barcode which is an unique ID. The Start and End
variables denote the base coordinates of the affected region. Segment Mean is a value
calculated from the copy number of a region with the formula: log2(copynumber/2), so
diploid regions have a segment mean of zero, amplified regions have a positive value and
deletions a negative one.
having several records for the same sample, regions containing more than one gene, or genes
being split into different regions. See figure 3.6. This format is not suited for high-level
analyses like clustering, neither for integration with expression data which uses a matrix of
genes by samples. A transformation to such format was necessary in order to perform data
integration. Fortunately, the CNTools package provided the means to perform the task.
The R code for generating a reduced segment dataset2 is showed in figure 3.7. First a CNSeg
object is created by passing the raw segments.dataset as argument. Then the function
getRS does the heavy transformation work. Important arguments are:
1. by: indicates the resulting features, in this case genes.
2. what: value to use when more than one segment includes the same gene. Mean values
2This is a term used by the creators of CNTools, which refers to the resulting dataset that has a single
measurement per sample/feature combination.
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seg <− CNSeg( s e g L i s t = segments . da ta se t )
rsByGene <− getRS ( seg , by = ” gene ” , what = ”mean” , geneMap = gene .
map . datase t )
r e s u l t <− r s ( rsByGene )
write . csv ( x = r e s u l t , f i l e = output . path )
Figure 3.7: Code for generating a segment reduced set with genes as features for each sample.
Figure 3.8: The resulting gene copy number dataset. Has one value for each sample/gene
combination.
were used for this case.
3. geneMap: a dataset that contains the base coordinates and chromosome number
for each gene. A custom set was generated using the BioMart online tool using the
GRCh38 genome version, which is the same used by the Genomic Data Commons
datasets.
The generated set is extracted using the rs function and then persisted to a .csv file. Still,
some cleaning steps similar to those applied to the expression datasets were necessary,
namely: reassigning row names, keeping only protein coding genes, modifying barcodes and
eliminating unnecessary variables (like base coordinates and chromosome number). After
these steps were effectuated, the gene copy number dataset was in tidy form and ready for
being used. See figure 3.8.
3.3.4 Extra Normalization Steps
The distributions of values for gene (mRNA) expression variables were found to be highly
skewed (differences between gene expression levels were sometimes exponential), so log2
transformations were applied for the ease of treatment and visualization. On the other
hand, miRNA expression variables did not need this transformation.
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Figure 3.9: High level view of the training procedure.
Both gene (mRNA) and miRNA Expression variables were z-normalized, a step necessary
so they could be integrated together under the same data table.
3.4 Implementation and Visualization of Hopfield Model
3.4.1 Training and Recall Procedures
According to the method used by [22], using the Hopfield Network as a clustering procedure
requires training the network (using the Hebbian rule) with each sample’s binarized vector3
(whose dimension is equal to the number of used features). Inputs can be binarized using a
sign function which assigns 1 to values higher than 0 and -1 otherwise. See the figure 3.9
for a high level view of the training procedure.
Then the recall function is applied to each one of those same vectors, where inputs that
converge to the same attractor state are considered to belong to the same cluster. See also
figure 3.10.
3.4.2 Implementation Details
For implementation purposes, an example code from the course “Foundations of Neural and
Cognitive Modeling” of the University of Amsterdam was used as base4. Logic is split into
3In this case the term binarized refers to having only two types of values (not strictly 0 and 1). For the
present context values are -1 and 1, indeed. Hope this clarification will avoid future misunderstandings.
4http://www.illc.uva.nl/LaCo/clas/fncm13/assignments/computerlab-week4/.
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Figure 3.10: High level view of the recall procedure.
two different functions, one for training the network, i.e generating the matrix of weights,
and the other for recalling memories (associating inputs with attractor states). Some minor
modifications were made to the code. These included:
1. Substituting uses of base matrix R objects with Matrix S4 objects, more suited for
higher computation rates and an efficient representation.
2. The outer product of the training equation 2.1 was calculated with the function
tcrossprod, which overall is more efficient for this case.
3. The recalling function was modified to add the possibility of tracing convergence routes
from the initial vector state to the final attractor state. This is done for visualization
purposes and is described below.
The training function is very simple and relies mostly on linear algebra matrix operations.
See figure 3.11. The function receives as a parameter a matrix of training inputs called
patterns. It is assumed that these patterns are already in a binarized state (only have +1
or -1 values). The number of computing units (or neurons) N is determined by looking at the
length of the first input pattern. Then the matrix of weights is initialized with dimensions
N by N , and with a zero on each entry. The sum of outer products is calculated in a loop
using the tcrossprod function. As the final steps, entries of the matrix’s diagonal are set
to 0 and values are normalized by the number of training patterns so each entry has a value
between -1 and 1 (in a manner similar to most correlation coefficients).
The recalling function is showed in 3.12. It receives the following parameters:
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create . h o p f i e l d . network . hebbian <− function ( pat t e rn s ) {
number . o f . neurons = length ( pa t t e rn s [ [ 1 ] ] )
weights <− Matrix (0 , number . o f . neurons , number . o f . neurons )
for ( i in 1 : length ( pa t t e rn s ) ) {
weights <− weights + tc ro s sp rod ( Matrix ( pat t e rn s [ [ i ] ] ) )
}
diag ( weights ) <− 0
weights <− weights / length ( pa t t e rn s )
return ( l i s t ( weights = weights ) )
}
Figure 3.11: Hopfield Network training function
1. hopfield.network.object: Contains the matrix of weights from a previously trained
network.
2. pattern: The input pattern that will be transformed into one of the attractor states
stored in the network.
3. max.iterations: The maximum number of iterations (neuron updates) to try. The
needed number of iterations increases with the quantity of features. It is worth men-
tioning that the update rule implemented on the function is asynchronous (neurons
are updated one at a time), so each iteration performs a single update.
4. replace: Describes the way neurons are selected when updating them. If the parameter
is set to FALSE, all neurons need to be updated before proceeding to the next round of
updates. Otherwise neurons will be picked completely at random. In practice, the last
option showed higher possibilities of converging to spurious attractors (local minima),
so it was avoided when performing the experiments.
5. trace.route.mode: A flag indicating whether to trace intermediate states for vector
y. These can be used for visualization purposes.
The result of executing the function is a vector representing the attractor state to which
the input converged. If the trace.route.mode flag was set, then the result also contains a
sequence of intermediate states.
3.4.3 Visualization Method
One of the interesting modeling points of the Hopfield Network is the capacity of representing
a landscape with physical properties similar to the ones exposed in Waddington model of
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run . h o p f i e l d <− function ( h o p f i e l d . network . object , pattern , max.
i t e r a t i o n s =100 , replace=FALSE, trace . route .mode = FALSE) {
y = pattern
number . o f . neurons = dim( h o p f i e l d . network . ob j e c t $weights )
[ 1 ]
t r a n s i t o r y . points <− NULL
i f ( trace . route .mode) {
t r a n s i t o r y . points <− data . frame ( )
}
order = c ( )
converge = FALSE
for ( i t in 0 : (max. i t e r a t i o n s −1) ) {
i f ( i t %% number . o f . neurons == 0) {
i f ( converge == TRUE) {
print ( ’ reach a s t a b l e s t a t e ! ! ! ’ )
break
} else i f ( trace . route .mode) {
t r a n s i t o r y . points <− rbind (
t r a n s i t o r y . points , c (y , energy (
y , hopnet ) ) )
}
order = sample ( 1 : ( number . o f . neurons ) ,
replace=replace )
converge = TRUE
}
i = order [ i t %% number . o f . neurons + 1 ]
y i . old = y [ i ]
z = h o p f i e l d . network . ob j e c t $weights [ i , ] %∗% y
y [ i ] = sign ( z )
i f ( y i . old != y [ i ] ) {
converge = FALSE
}
}
i f ( ! trace . route .mode) {
return ( y )
} else {
return ( l i s t ( a t t r a c t o r = y , t r a n s i t o r y . points =
t r a n s i t o r y . points ) )
}
}
Figure 3.12: Hopfield Network recalling function
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cellular differentiation. This is useful for identifying, at least in an intuitive way, the relative
distance between attractor states and properties like the size of their basins of attraction, i.e
how big is the influence each attractor exerts on nearby vectors.
In [22] a visualization method is proposed. It consists in performing a principal component
analysis of the training samples, then using the first two principal components as the x-axis
and y-axis of the plot. Detected attractor states are also projected alongside the cases. A
third z-axis is also added, which corresponds to the energy levels of the cases (a Lyapunov
function). Cases with low energy levels are closer to attractor states that those with high
levels. Given a vector S, the energy level can be calculated with the following formula:
E(S) = −1
2
STWS. (3.1)
This function can be easily implemented in R with the following code. Note the use of the
%*% operator for matrix multiplication:
energy <− function ( point , network ) {
return (−0.5 ∗ ( as . numeric ( t ( po int ) %∗% network$weights %∗
% point ) ) )
}
The described method is useful for checking clustering results but does not necessarily reveal
all attractor states in the network and their convergence paths. A monte carlo inspired
visualization method that does not depend of a set of training samples was created as a
support tool for this project.
The idea is fairly simple. A lot of random points are generated (binary vectors of size N) and
these are recalled using the matrix of weights from the network that needs to be visualized.
Transitory states for the points are captured as well. By using this randomized process, the
network’s attractors and their positions can be discovered.
The intuitive idea behind this method is the following. Imagine an object that physically
exists in space (has volume and mass) but it cannot be seen for some reason. One could
try to pour some painting on the object to reveal its contours and shape. This is analogous
to generating a lot of random points and made them all converge to some attractor state.
The trajectories followed by the points will always be downward (as the z-axis represents
the energy, which becomes progressively lower as the vectors get near an attractor state).
The end result is a drawing of the landscape. See figure 3.13 for an example. This method
reinforces the notion that the Hopfield Network tends to cluster points around the perimeter
of a circle in a symmetric way. Points separated by an angle of 180 degrees are complementary
binary vectors, so it is safe to say that every attractor has a polar opposite.
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(a) Visualization using scatterplot3d package. (b) Visualization using rgl package.
Figure 3.13: Example of visualizing a Hopfield Network’s landscape using the custom vi-
sualization method. The z-axis corresponds to the energy function. Red dots are initial
states which are generated randomly with an uniform distribution. Green dots represent
intermediate states and serve to trace possible convergence paths. Black dots are attractor
states (either local minima or maxima). The visualized network corresponds to one that has
stored a couple of binarized patterns for all even digits (2, 4, 6, 8, 0).
3.5 Experimental Design
The experiments were organized following a factorial design of 3 ·4 ·6 (three different factors
with three, four and six levels respectively). In a factorial design, runs are distributed
equally across all the different experimental conditions that the levels of factors dictate
(72 combinations on this case). This allows to later measure possible joint effects between
independent variables into the dependent ones.
3.5.1 Independent Variables (Factors)
There were three different factors involved in the experiments: the genomic dataset, the
clustering algorithm and the number of used features.
Genomic Dataset
The diversity of multi-omic data from the TCGA provides different data views for the same
cancer samples. This opens up the door to performing interesting data integrations that
might yield features with better discrimination characteristics than the ones from single
datasets. The datasets (alongside its respective codes) for this factor were the following:
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1. Gene (mRNA) Expression - GE: a dataset containing only the expression rates for the
protein coding genes. These values are normalized using the FPKM (Fragments Per
Kilobase of transcript per Million mapped reads) procedure.
2. Gene Copy Number - GCN: a dataset containing the copy number values of genes
as log2(copy − number/2). These are calculated as described in the “Tidy Dataset
Generation” section.
3. miRNA Expression - MiRNA: this dataset contains the expression values for genes that
code for miRNAs. These values are normalized under the RPM (Reads per Millions)
procedure.
4. Gene (mRNA) Expression integrated with miRNA Expression - GE + MiRNA: an
early integration approach is followed. That is, the variables of the two datasets are
merged into one new dataset. A small minority of samples with mRNA measurements,
but lacking the miRNA ones were discarded.
5. Gene (mRNA) Expression values divided by Gene Copy Number - GE + GCN: the
values of this dataset are generated by taking each gene expression value and diving
it by the corresponding raw gene copy number value. To obtain these raw values the
inverse function of log2(copy − number/2) is applied.
6. Gene (mRNA) Expression values divided by Gene Copy Number and then integrated
with miRNA Expression - GE + GCN + MiRNA: this dataset is obtained by taking
the previous one and then performing an early integration approach with the miRNA
expression dataset.
Clustering Algorithm
Testing clustering algorithms other than the Hopfield Network it is important from a valida-
tion standpoint. Given the complicated noisy nature of gene expression data, any clustering
algorithm might encounter problems establishing clear divisions between groups. So using
other algorithms might give an insight of how much is noise in the data affecting the results,
or, if one algorithm is clearly better than others for the type of data. Tested algorithms
were:
1. Hopfield Network: the main algorithm of interest for the study. It does not need
an initial number “k” of expected clusters. Theses are determined by the resulting
attractors which act as representative elements of the cluster. It works on binary data
only.
2. OPTICS: a density-based clustering algorithm similar to dbscan [2]. Works better
with clusters of variable density, and similarly to Hopfield’s method, does not require
an initial “k”. Given that the algorithm requires a cut point (similar to hierarchical
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clustering), an heuristic was followed to determining such. Different cuts are tried in
an incremental fashion until the outliers (points not assigned to any cluster) ratio is
below 15%. The cut point is still increased until the established clusters begin to merge
together. Previous to that moment, the cut is chosen and remaining points which don’t
belong to any cluster are assigned to the one which is nearest respectively.
3. K-means: a classic algorithm in clustering literature. It needs a value of “k”, which
was set to 4 (the number of known breast cancer types).
Number of Used Features
Features were chosen using a simple filtering method. These were ranked using BSS/WSS
ratio (between-group sum of squares divided by within-group sum of squares). A way of
rephrasing this it’s by saying that features that have high variance between groups and low
variance within groups generally have better discriminative power than other features. The
groups on this case correspond to the four groups of breast cancer involved in the study.
Once ranked, features were chosen by picking the ones with the top n values, which are 10,
25, 50 and 100 for this factor.
In general, the miRNA variables showed BSS/WSS ratios much smaller than the ones from
mRNA variables. So rankings were applied separately in case the two types of variables were
integrated together and a selection ratio of 20% was used for the miRNA variables, while
the remaining 80% for the other type of variables. For example, if 100 features were used,
20 would be the top miRNA variables and the remaining 80 would be the top mRNA.
3.5.2 Dependent Variables
Excluding basic measurements like the number of generated clusters and running time,
the dependent variables corresponded mostly to external validation measures, i.e., knowledge
about the problem’s domain was used for calculating these metrics. The PAM50 [50] breast
cancer labels provided by the “TCGABiolinks” package were used to create a reference
clustering that serves as groundtruth prior to each experimental run. It is composed of four
clusters, one for each molecular subtype of breast cancer.
The dependent variables were the following:
Number of Generated Clusters
The number of generated clusters.
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Running Time in Seconds
Wall clock time taken to execute the clustering algorithm. It does not include time to
normalize values or choose features.
RAND Index
A symmetric measure of similarity between two clusterings C and C ′ in terms of much they
agree when placing pairs of points into the same (or different) cluster. It ranges from -1 to
1, with positive values indicating a certain degree of agreement. It’s important to notice
that the clusterings don’t need to have the exact same number of clusters in order to have
an acceptable RAND index. As long as certain structure is preserved the results might be
good. The index is calculated with the following formula:
R =
a + b(
n
2
)
Here the denominator is equal to the number of all possible pairs that can be made with
the n elements. In the numerator we have the sum of two values: a which is equal to the
number of pairs where both elements belong to the same cluster in both C and C ′, and b,
the number of pairs where both elements belong to different clusters on both C and C ′.
ARI (Adjusted RAND Index)
A corrected for chance version of RAND Index:
ARI =
Index− ExpectedIndex
MaxIndex− ExpectedIndex
Basically it excludes the possibility of obtaining good scores by chance, so index values tend
to be a lot lower compared to the plain RAND index.
Other Measures
These include precision, recall, sensitivity and specificity. See Annexes. Note that in the
context of clustering, a true positive is translated in a pair where the two elements belong
to the same cluster on both the result and groundtruth. On the other hand, a true false is
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a pair where the elements belong to different clusters, and both the result and groudtruth
agree on this. Note that recall and sensitivity are the same, but the same not applies to
precision and specificity.
3.5.3 Conditions Across Runs
1. Memory clean up: The garbage collector of R is triggered before each run with the
intend of normalizing the available memory across different runs.
2. Used cases: Stratified random sampling is performed in order to choose an equal
number of cases (82) from each of the four subtypes of breast cancer.
3. Replicas: Each of the 72 experimental conditions had 10 different runs for a total of
720. Results were averaged.
4. PCA views: Principal Component Analysis plots are generated for each run, both for
the actual results and the groundtruth clustering.
5. Normalization: Gene (mRNA) expression variables are log transformed and Z-score
normalized before any of the runs. The log transformation is not applied to miRNA
varibles or gene copy number values.
Chapter 4
Results and Discussion
This chapter highlights the most relevant results obtained through the implementation and
execution of the experimental design detailed in the previous chapter.
4.1 Initial Considerations
Prior to the analysis of any measured dependent variable, is worth mentioning some im-
portant results. Both the standalone miRNA Expression and Gene Copy Number datasets
(coded as MiRNA and CN respectively) did not show any apparent clustering structure (with
ARIs very close to 0). A possible explanation is that their features alone are not enough to
make a good discrimination between groups. PCA plots show how unsuitable these datasets
are for clustering. See figures 4.1 and 4.2. All algorithms performed poorly on this regard.
Even if clustering results seem bad, its worth noting that the data might serve for detecting
outliers. Isolated points are clearly visible on both types of data.
The results associated with the standalone MiRNA and CN datasets are omitted in future
calculations, as the average values of metrics could be highly distorted provoking a false
sense of misquality.
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(a) Groundtruth classification. (b) Hopfield classification.
Figure 4.1: Principal Component Analysis view of the sample from one of the experimen-
tal runs using the Gene Copy Number dataset with 10 features. Samples don’t form any
recognizable group.
(a) Groundtruth classification. (b) Hopfield classification.
Figure 4.2: Principal Component Analysis view of the sample from one of the experimental
runs using the miRNA expression dataset with 10 features. All samples tend to cluster
together into a single group.
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Figure 4.3: Box plot showing the distribution of ARI values for the evaluated algorithms.
Means are marked with a diamond.
Figure 4.4: Box plot showing the distribution of RAND values for the evaluated algorithms.
Means are marked with a diamond.
4.2 General Results
4.2.1 Clustering Accuracy
ARI and RAND values distributions for each algorithm are showed in figures 4.3 and 4.4.
Hopfield shows a mean ARI around 0.31. The algorithm appears to be very stable across
all conditions and shows little variability. OPTICS, on the other hand seems to be highly
variable with values ranging from 0 to 0.52, having a mean ARI around 0.23. This variability
is product of the number of used features and dataset (see sections below). Kmeans shows
the highest scores with a mean of 0.53. This is expected as Kmeans is hinted to create four
clusters, which gives it an extra edge above the other algorithms. Still is interesting to make
comparisons.
The figure 4.5 shows in a more detailed manner, the distribution of ARI values for all the
possible experimental conditions. Points to highlight include:
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1. Hopfield performance shows little to no variation, with the possible exception of the
GE+CN with 100 features combination that shows a little.
2. OPTICS performance appears to get worse as more features are added. All the runs
with 100 features got an ARI of 0 which means it detected a single cluster. On the
other hand, GE+CN with 10 features got the better results with a maximum ARI of
0.51 which is considerable good.
3. Kmeans achieves its greatest performance using GE+MiRNA+CN with 100 features.
It shows little variation under this configuration and reaches a top ARI of 0.68 which
is unusually high for this type of data.
These points are explored more carefully in the sections below.
4.2.2 Number of Detected Clusters
The distribution for the detected number of clusters for each algorithm is shown in figure
4.6. It can be seen that both Hopfield and OPTICS detect two clusters most of the time.
There is a small minority of times where Hopfield detects more than two (three, four or five).
As will be seen later, only the case of three clusters is relevant, as the other two (four and
five) incorporate clusters with a single element. OPTICS has a considerable number of cases
with a single cluster (case with ARI of 0), and some with three. Kmeans always ends with
four clusters because it was configured to do so.
4.2.3 Execution Time
The computer used for execution had a processor Intel(R) Core(TM) i5-2450M CPU 2.50GHz
with 4,00 GB of RAM. Wall clock times for algorithms are showed in figure 4.7. It is clear
that the Hopfield algorithm is very expensive in comparison with the others. This poses
a major drawback to consider, as adding features appears to affect the execution time of
Hopfield in a non-linear way.
Hopfield’s performance could be explained by the following two points:
1. First of all, the algorithmic complexity. The one from Hopfield’s might be several orders
above in comparison with Kmeans and OPTICS which have implementations as good
to be in Θ(n) and Θ(n log(n)) respectively. Only the recall phase from Hopfield requires
a cost equivalent to several matrix multiplications, each having a cubic complexity; and
this is repeated for each sample.
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Figure 4.5: Box plot showing the distribution of ARI values for all the experimental condi-
tions. X-axis varies the datasets, while y-axis the number of used features.
4.3. DISCUSSION POINTS 57
Figure 4.6: Violin plot showing the distribution for the detected number of clusters for each
algorithm.
2. Hopfield’s implementation was made completely in R and was no optimized by any
means.
4.3 Discussion Points
4.3.1 Hopfield Remarks
Most of the experimental runs of Hopfield detect two clusters instead of the expected four.
As a result, precision values are quite low (around 0.40). The recall values on the other hand
are relatively high with a mean around 0.84. Inspecting some results visually, it seems that
Hopfield clusters together all the luminal samples (both A and B types), and it does the
same for the HER2 and basal ones. This can be easily appreciated in figure 4.8.
Inspecting the two generated attractors it can be seen that they are complementary (the
sum of them gives a zero vector). This phenomenon appears to be a property of Hopfield
Networks, that is, every attractor state has its polar opposite. However, this might not be
desirable from a biological modeling point of view. The statement made in [22] of inter-
preting the attractor states as characteristic configurations of types of cancer might not be
straightforward as it sounds. After all, it makes little sense to state that a type of cancer is
a polar opposite of another in terms of gene expression.
There was a single experimental condition (GE + CN dataset with 100 features) where
Hopfield obtained some conspicuous results. The emergence of a third cluster was clearly
established as seen in figure 4.9. The third cluster appears to group a high number of luminal
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Figure 4.7: Lines plot showing the mean execution times for the evaluated algorithms. Time
is measured in seconds.
(a) Groundtruth classification. (b) Hopfield classification.
Figure 4.8: Principal Component Analysis view of the sample from one of the experimental
runs using the Gene (mRNA) expression dataset with 10 features.
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(a) Groundtruth classification. (b) Hopfield classification.
Figure 4.9: Principal Component Analysis view of the sample from one of the experimental
runs using the GE + CN (gene expression values divided by copy number) dataset with 100
features.
B cases, which gave a slight improvement of precision and a considerable one in specificity
(true negative rate increased from a mean value of 0.59 to 0.70). Still ARI values are similar
to the other experimental conditions. Some single (or two) element clusters also appeared.
Most probably, are cases of local minima in the Hopfield landscape. It would be interesting
to validate if these cases correspond to outliers in some form.
Overall, the Hopfield Network’s property of having at least two attractors might pose some
doubts about its effectiveness for clustering. It might be argued, that the clustering structure
is a result of the method and no of the data. Surprisingly, this might be useful in some cases
for data that contains clusters connected by bridges (density based algorithms might fail on
this regard). Still, a more careful evaluation is necessary.
Also, the fact that a third cluster appeared as the result of a high number of features (100)
poses a interesting question in terms of how the number of features affects the quantity of
attractors in the network. From an information point of view, a higher number of features
means more capacity of having different states in the network [23]. In the context of biological
problems that have a lot of variables, further exploration of this characteristic might be
interesting.
4.3.2 OPTICS Remarks
Similar to the Hopfield algorithm, OPTICS only detected two clusters most of the time.
However, while Hopfield tended to create a group exclusively for luminals and another for
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(a) Groundtruth classification. (b) OPTICS classification.
Figure 4.10: Principal Component Analysis view of the sample from one of the experimental
runs using the Gene (mRNA) expression dataset with 10 features.
HER2/basal samples, OPTICS separated the basal ones into their own cluster and put the
rest of samples together. Notice that in figure 4.10 the achieved recall was perfect (equal to
1). This means that all element pairs that should go together are indeed grouped inside the
same cluster. This is somewhat meritorious as long there is more than one cluster.
OPTICS in general, appears to behave worse as the number of features is increased. See
figure 4.11. It even reaches the point of detecting a single cluster when using 100 features.
From the PCA view (figure 4.12) it can be seen that points become less coupled together in a
high dimensional space, so it can be understood that a density-based approach for clustering
might fail.
The experimental condition that obtained the best results for OPTICS (and most interesting,
overall) was using the GE + CN dataset with only 10 features. Under this configuration it
detected three well-defined clusters on seven out of the ten runs. It managed to group the
majority of HER2 cases into a separate group (see figure 4.13).
Ten is a remarkable low number of features for a cancer diagnostic test (see Table 4.1 for
the gene list). For example PAM50 uses 50, and Oncotype DX uses a 21 gene-assay. Even
if the model does not differentiate between luminal A and B, the low number of required
features somehow compensates. These results, mixed with the fact that were only obtainable
by dividing gene expression values by the copy number ones, look promising for further
exploration and research. It hints at the possibility of implementing good diagnostic tests
at a lower cost.
In the PCA biplot of the figure 4.14 the correlations between variables and how they impact
the different groups can be appreciated. The basal group is strongly affected by the expres-
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Figure 4.11: Line plot showing the mean ARI values for OPTICS algorithm while varying
the number of used features.
(a) Groundtruth classification. (b) OPTICS classification.
Figure 4.12: Principal Component Analysis view of the sample from one of the experimental
runs using the Gene (mRNA) expression dataset with 100 features.
62 CHAPTER 4. RESULTS AND DISCUSSION
(a) Groundtruth classification. (b) OPTICS classification.
Figure 4.13: Principal Component Analysis view of the sample from one of the experimental
runs using the GE + CN (gene expression values divided by copy number) dataset with 10
features.
Gene ID Gene Name Gene Synonyms Description
ENSG00000054598 FOXC1 ARA, FKHL7,
FREAC3, IGDA,
IHG1, IRID1
forkhead box C1
ENSG00000074410 CA12 HsT18816 carbonic anhydrase 12
ENSG00000091831 ESR1 ER-alpha, ESR,
Era, NR3A1
estrogen receptor 1
ENSG00000107485 GATA3 HDR GATA binding protein 3
ENSG00000109436 TBC1D9 GRAMD9,
KIAA0882,
MDR1
TBC1 domain family mem-
ber 9
ENSG00000115648 MLPH Slac-2a, exophilin-
3, l(1)-3Rk,
l1Rk3, ln
melanophilin
ENSG00000124664 SPDEF PDEF,
bA375E1.3
SAM pointed domain con-
taining ETS transcription
factor
ENSG00000129514 FOXA1 HNF3A forkhead box A1
ENSG00000173467 AGR3 BCMP11, HAG3,
PDIA18, hAG-3
anterior gradient 3
ENSG00000182175 RGMA RGM, RGMa repulsive guidance molecule
BMP co-receptor a
Table 4.1: The ten genes used for OPTICS best performance scenario. Information taken
from “ensembl.org” website.
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Figure 4.14: A PCA biplot using the majority of breast cancer samples from the TCGA
with the 10 genes GE + CN dataset. Red points are basal samples, light green triangles are
HER2, squares and crosses are luminal.
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(a) Groundtruth classification. (b) Kmeans classification.
Figure 4.15: Principal Component Analysis view of the sample from one of the experimental
runs using the GE+MiRNA+CN dataset (gene expression values divided by copy number
and also integrated with miRNA variables) with 100 features.
sion of FOXC1 and RGMA genes, and posses low expression rates for MLPH and FOXA1.
Luminal samples are strongly affected by the expression of several genes, most notoriously
the ESR1. There are no arrows pointing towards the HER2 group, so these are discriminated
by some of the genes highly expressed in the luminal samples, but not in them. The biplot
also reveals arrows that are very close together (features with high positive correlation). A
strong correlation between variables reveals a certain degree of redundancy between them.
All these details might be used to improve the selected features.
4.3.3 Kmeans Remarks
Kmeans, maybe in an expected way, obtained the highest ARI values. The precision was im-
proved merely by the fact of hinting the algorithm to produce four groups (the same number
of clusters in the groundtruth). Despite this, the algorithm showed great variability across
runs in the way it clustered the samples. On some runs it divided the basal samples into
two separate groups, and on others the luminal ones (not reflecting the A and B subtypes).
Most of the times, a representative cluster for the HER2 type was created.
Curiously, the best results for Kmeans were show using the GE+MiRNA+CN dataset (that
is, the three types integrated together) with 100 features. One of the runs reached an ARI
of 0.68 and a precision of 0.91, the highest among all the runs for all the configurations (see
figure 4.15). Under this configuration the variation phenomena described in the paragraph
above it’s still present across runs, with the difference that the group of luminal samples, if
divided, it is better separated into the A and B subtypes.
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How much the miRNA variables really contributed to the results is something not entirely
clear at first glance. Given the little discriminative power that miRNA variables showed
(via their BSS/WSS ratios) in comparison to the mRNA ones, the result is kind of interest-
ing. A possibility is that miRNA variables did introduce less noise (hence the unexpected
improvements), on which case the contribution to the separation of classes might not be
significant.
Chapter 5
Conclusions and Future Work
This chapter concludes with the most important remarks and lessons acquired through the
elaboration of this research.
5.1 General Conclusions
Cancer is still one of the greatest challenges humankind has ever faced. However, if we look in
retrospective, the understanding that has been generated in recent years is considerable and
trans-disciplinary action has played a key role on it. Molecular biologists cannot cope with
the amounts of data that are being generated and need the aid of computational tools both
for processing and analyzing patterns. Clustering is only one example of how the “divide and
conquer” approach is useful for tackling something as complex as cancer. After all, breaking
a disease down into different scenarios helps to structure strategies for treatment.
Public repositories of data, such GDC/TCGA, have opened the opportunities for new type
of studies to be made. The quantity and quality of data are factors to consider when trying
to answer a biological question. Fortunately, having a common repository available for the
scientific community helps in terms of reproducibility and standardization. Of course, having
a great diversity of omic data types (mRNA, miRNA, copy number variation...) introduces
the challenge of figuring out how to use them together to gain a more solid understanding of
the dynamics underneath. There is still room for trying new data integration strategies, such
as in this study, where dividing gene expression values by their corresponded copy number
improved the discrimination of breast cancer types in some scenarios. This in turn poses new
research questions. Could it be that normalizing the gene expression in that way minimizes
the noise caused by the over expression of some genes?
Regarding the topic of clustering, definitely there is no best universal algorithm. It entirely
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depends of several factors like: the shape of data, the quantity of noise and the external
knowledge about the problem. Gene expression is a particularly difficult type of data to
dealt with, beginning by the fact that it has an overwhelming number of features that do
not follow uniform distributions by any means. Normalization and feature selection are vital
processes for a successful data analysis in genomics, and are as important, if not more, than
the training/classification algorithm itself.
The Hopfield clustering algorithm studied on this research had certain characteristics that
made it appealing for experimenting on genomic data. The most notorious of these character-
istics was its convergence dynamics which might resemble a cellular differentiation process.
However, the mirror attractor phenomena present in the network (every stable state has
its polar opposite) puts the biological modeling in question, as it makes no sense on a real
scenario. Even if samples are perfectly clustered, the information contained in the attractor
states might be misleading, or at least, should be interpreted very carefully. Also, its remark-
able strange having a clustering algorithm that has no parameter other than the data, which
is binarized and subject to information loss. On the bright side, the algorithm has interesting
properties, and appears to have more information storage capabilities as more features are
added (states have more coding power). This characteristic, plus the fact that the hebbian
learning scheme does not depend on a distance measure, might render the algorithm useful
for problems with a high number of features. Still, the complexity of the algorithm poses a
drawback to consider if implemented.
Finally, despite all the objectives of the study being fulfilled, the main hypothesis did not
hold completely:
Through the use of multi-omic data from the TCGA and a hebbian learning
scheme, is possible to create a Hopfield Network model for breast cancer subtyp-
ing and characterization. This model will either differentiate between the main
four molecular subtypes of breast cancer, or will find a finer classification inside
these.
A model for breast subcancer was created indeed, but was not able to differentiate completely
between the main four molecular subtypes, and even less, a subclassification inside them.
In addition, the ”characterization” aspect of the model is affected by the properties of the
attractors and their opposites. However, valuable new hypothesis can be derived, that is,
the possibility of creating a model with few genes that discriminates between luminal (both
A and B), basal and HER2 groups.
5.2 Limitations
There were two main limitations for the study:
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1. First, a simple and single strategy was used for feature selection. There are a good
variety of algorithms in the literature. At least other two can be used and contrasted.
2. Second, the miRNA integration strategy did not suit well the feature selection method
that was used. This is because the BSS/WSS ratio of miRNA variables is relatively
low if compared to the mRNA ones. If a single ranking of variables is applied then
the miRNA features are left out completely. This fact hints that there could be more
intelligent ways of integrating this type of data.
5.3 Future Work
The most relevant result, maybe in an ironical way, was obtained not by using the Hopfield
Network, but the OPTICS algorithm. This result, hinted at the possibility of having a precise
prediction model with a low quantity of features (10 on this case). Even if the model does
not differentiate between luminal A and B subtypes, the good discrimination it makes for
other types and its low cost makes it promising for further exploration. In a very optimistic
scenario, a diagnostic test that uses only 10 genes would be very economical in comparison
to other tests like PAM50 which use 50.
There are several ways the model could be improved. A close examination of the optimal
number of features should be made, this time putting emphasizing in a narrow range like
5 . . . 15. Knowing that is possible to separate the samples into three well-formed groups (lu-
minal, HER2 and basal), supervised models could also be explored (using a single “luminal”
label instead of two). Also, in order to relax the problem of differentiating between luminal
A and B, a separate model could made with the exclusive task of discriminating between
these two groups. That would be used in a second step if the first model dictates a “luminal”
output. As long the total number of used genes is relatively low, then having a hierarchical
organization of predictive models is a viable option.
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Annexes
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6.2 Sensitivity and Specificity
Images taken from wikipedia.org and licensed under Creative Commons Attribution-Share
Alike 4.0 International.
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